InVivo: InVivo Therapeutics : Termination of Material Agreement - Form 8-K

(marketscreener.com) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 of the Securities Exchange Act of 1934 August 29, 2023 Date of Report ...https://www.marketscreener.com/quote/stock/INVIVO-THERAPEUTICS-HOLDI-42809903/news/InVivo-Therapeutics-Termination-of-Material-Agreement-Form-8-K-44757850/?utm_medium=RSS&utm_content=20230901